Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 2020

View Archived Issues

Calpain-2 in common, rare neurodegeneration

Antitoxin vaccine fights S. aureus

Phase I study of DWP-710 approved in Indonesia

Preclinical data presented for anti-CD33 JNJ-67571244 in AML

Novel CLDN18.2-targeted 4-1BB bispecific antibody with potent antitumor activity

BOP1 as new prognostic biomarker in melanoma

AIDS2020: Virtual -- Can state of the ART get to "see you next year"?

Insilico Medicine patents TLR7 and/or TLR8 antagonists

Global Blood Therapeutics divulges SLC40A1 inhibitors

Esteve Pharmaceuticals presents new analgesics

Bicyclerd identifies new IL-17 ligands

Eternity Bioscience patents hSTING receptor agonists

Angion begins phase II study in Brazil with ANG-3777 in patients with COVID-19 pneumonia

NextCure initiates phase I/II trial of LAIR-2 biomimic NC-410

New anti-PD-1 antibody YBL-006 shows high receptor affinity, in vivo activity

DECR1 unveiled as a potential therapeutic target in prostate cancer

Enrollment completed in phase II study of mRNA-1273 for COVID-19

Indivior begins first-in-human study of INDV-2000 for opioid dependence

FDA approves IND for phase I/IIa study of FCR-001 for diffuse systemic sclerosis

Asieris cleared in China to begin global phase III trial of Cevira for high-grade cervical dysplasia

Reverie and Roche establish multi-target collaboration

Constant's TXA-127 to be studied for COVID-19 in phase II trials

Numab begins first-in-human study of NM21-1480 for advanced solid tumors

New phase II study evaluates RUC-4 in patients with STEMI

RefleXion and Telix to study combining technologies for prostate and renal cancers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...